Patients were stratified by previous docetaxel use , baseline total alkaline phosphatase level , and current bisphosphonate use , then randomly assigned ( 2:1 ) to receive either six intravenous injections of radium-223 ( 50 kBq/kg ) or matching placebo ; one injection was given every 4 weeks .